Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
A new era of metal-based drugs started in the 1960s, heralded by the discovery of potent platinum-based complexes, commencing with cisplatin [(H3N)2PtCl2], which are effective anti-cancer chemotherapeutic drugs. While clinical applications of gold-based drugs largely relate to the treatment of rheum...
Main Authors: | Chien Ing Yeo, Kah Kooi Ooi, Edward R. T. Tiekink |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/6/1410 |
Similar Items
-
Synthesis and evaluation of nitrogen-and phosphorus-donor platinum and gold complexes as anti-cancer agents
Published: (2010) -
Bioconjugation reactions of peptides and proteins mediated by manganese, ruthenium and gold compounds
by: Chan, On-yee., et al.
Published: (2013) -
Gold Compounds and the Anticancer Immune Response
by: Ling Zhou, et al.
Published: (2021-09-01) -
The anti-cancer properties of cyclometalated gold(III) complexes and organogold(III) supramolecular polymers
by: Zhang, Jingjing, et al.
Published: (2015) -
[<i>O</i>-Isopropyl-<i>N</i>-(4-nitrophenyl)thiocarbamato-<i>κS</i>]-(tri-4-tolylphosphine-<i>κP</i>)gold(I)
by: Chien Ing Yeo, et al.
Published: (2018-11-01)